MyAverix Finance
US · Healthcare
ADC Therapeutics SA (ADCT)
Biotechnology
ADC Therapeutics SA (ADCT) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ADCT
ADC Therapeutics SA (ADCT) — FAQ
What is ADCT's P/E ratio?
The price-to-earnings (P/E) ratio for ADC Therapeutics SA (ADCT) is 25.00 (data as of 2026-05-23).
Does ADC Therapeutics SA pay a dividend?
Dividend yield is not available in the current snapshot for ADC Therapeutics SA (ADCT). Check the MyAverix Finance app for the latest dividend data.
What sector is ADC Therapeutics SA in?
ADC Therapeutics SA (ADCT) is classified in the Healthcare sector (Biotechnology industry).
What exchange is ADCT listed on?
ADCT is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.